Scrutiny In Store For Hong Kong’s First Advanced Therapy Rules
New Bill To Be Introduced In Legislative Council On 30 October
Requirements for advanced therapies in Hong Kong are being modeled on the EU regulatory regime.
You may also be interested in...
Hong Kong is consulting on proposals to include advanced therapies in its regulatory framework for pharmaceuticals.
Health technology assessment body NICE wants Kite to collect more evidence to prove that Tecartus can cure relapsed or refractory mantle cell lymphoma. But in the meantime, it says the CAR-T therapy should be made available on the National Health Service, making UK patients among the first in the world to be offered access to the treatment.
New medicines under evaluation at the European Medicines Agency.